DGCI grants approval for clinical trials for third dose of Covaxin
India | April 02, 2021 13:03 ISTThe expert panel of India's drug regulator, DCGI, has permitted Bharat Biotech to give the third dose of Covaxin to a few volunteers in its clinical trials of the COVID-19 vaccine.